SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001650664-24-000037
Filing Date
2024-05-08
Accepted
2024-05-08 16:21:43
Documents
57
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20240331.htm   iXBRL 10-Q 706408
2 EX-10.2 ex102amendmenttocollaborat.htm EX-10.2 22782
3 EX-31.1 edit-20240331xex311.htm EX-31.1 9643
4 EX-31.2 edit-20240331xex312.htm EX-31.2 9616
5 EX-32.1 edit-20240331xex321.htm EX-32.1 6207
  Complete submission text file 0001650664-24-000037.txt   4099702

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT edit-20240331.xsd EX-101.SCH 25520
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT edit-20240331_cal.xml EX-101.CAL 48348
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT edit-20240331_def.xml EX-101.DEF 113734
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT edit-20240331_lab.xml EX-101.LAB 444947
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT edit-20240331_pre.xml EX-101.PRE 281836
60 EXTRACTED XBRL INSTANCE DOCUMENT edit-20240331_htm.xml XML 496876
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 24926528
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)